TrialLancet (London, England)2023

NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial.

Zev A Wainberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.